SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges
Journal of Inflammation Research · 2026-01 · Volume 19 · 1-18
DOI: 10.2147/jir.s588949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-01. Verfasst von Fan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Changzhou Hospital of Xuzhou Medical University, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a significant microvascular complication of diabetes, characterized by a complex interplay between metabolic dysregulation and chronic inflammation. This review methodically elucidates the pivotal role of the deacetylase sirtuin 2 (SIRT2) within this pathological network. SIRT2, a nicotinamide adenine dinucleotide dependent metabolic sensor, deacetylates multiple substrates to regulate renal intrinsic cell functions (eg, podocytes and tubular epithelial cells). It suppresses nuclear factor kappaB and nod-like receptor protein 3 inflammasome pathways, modulates macrophage polarization, and influences "metabolic memory". However, these critical functions exhibit cell- and context-dependent specificity. For instance, in podocytes, SIRT2 maintains cytoskeletal stability by deacetylating α-tubulin. Conversely, in certain models of renal tubular injury, SIRT2 may exacerbate damage, underscoring its highly context-dependent function. Consequently, the targeting of SIRT2 (including the development of selective modulators and the exploration of combination therapies with existing treatments such as sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists) is considered a promising therapeutic strategy. Notwithstanding, SIRT2-targeted therapies face a multitude of challenges, including functional duality, tissue-specific delivery, and clinical translation. This necessitates meticulous evaluation for clinical application. Future efforts should leverage cutting-edge technologies to deepen mechanistic understanding and advance biomarker-guided precision medicine, thereby providing a theoretical foundation for novel DKD therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Affiliated Changzhou Hospital of Xuzhou Medical University, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China.
ORCID-Profile: Fan Zhang, Wenjian Li
Zitieren
APA
Zhang, F., & Li, W. (2026). SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges. Journal of Inflammation Research, Volume 19, 1-18. https://doi.org/10.2147/jir.s588949
Vancouver
Zhang F, Li W. SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges. Journal of Inflammation Research. 2026;Volume 19:1-18. doi:10.2147/jir.s588949
BibTeX
@article{Zhang2026,
author = {Zhang, Fan and Li, Wenjian},
title = {SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/jir.s588949}
}
EUVIMED